3.22.2.2 html 289 304 1 false 85 0 false 10 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.bicycletherapeutics.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Shareholders' Equity Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedStatementsOfShareholdersEquity Condensed Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 00305 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedStatementsOfShareholdersEquityParenthetical Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.bicycletherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 10101 - Disclosure - Nature of the business and basis of presentation Sheet http://www.bicycletherapeutics.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of the business and basis of presentation Notes 8 false false R9.htm 10201 - Disclosure - Summary of significant accounting policies Sheet http://www.bicycletherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of significant accounting policies Notes 9 false false R10.htm 10301 - Disclosure - Fair value of financial assets and liabilities Sheet http://www.bicycletherapeutics.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilities Fair value of financial assets and liabilities Notes 10 false false R11.htm 10401 - Disclosure - Property and equipment, net Sheet http://www.bicycletherapeutics.com/role/DisclosurePropertyAndEquipmentNet Property and equipment, net Notes 11 false false R12.htm 10501 - Disclosure - Accrued expenses and other current liabilities Sheet http://www.bicycletherapeutics.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued expenses and other current liabilities Notes 12 false false R13.htm 10601 - Disclosure - Long-term debt Sheet http://www.bicycletherapeutics.com/role/DisclosureLongTermDebt Long-term debt Notes 13 false false R14.htm 10701 - Disclosure - Ordinary shares Sheet http://www.bicycletherapeutics.com/role/DisclosureOrdinaryShares Ordinary shares Notes 14 false false R15.htm 10801 - Disclosure - Share-based compensation Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensation Share-based compensation Notes 15 false false R16.htm 10901 - Disclosure - Significant agreements Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreements Significant agreements Notes 16 false false R17.htm 11001 - Disclosure - Income taxes Sheet http://www.bicycletherapeutics.com/role/DisclosureIncomeTaxes Income taxes Notes 17 false false R18.htm 11101 - Disclosure - Commitments and contingencies Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingencies Commitments and contingencies Notes 18 false false R19.htm 11201 - Disclosure - Net loss per share Sheet http://www.bicycletherapeutics.com/role/DisclosureNetLossPerShare Net loss per share Notes 19 false false R20.htm 11301 - Disclosure - Related party transactions Sheet http://www.bicycletherapeutics.com/role/DisclosureRelatedPartyTransactions Related party transactions Notes 20 false false R21.htm 11401 - Disclosure - Geographic information Sheet http://www.bicycletherapeutics.com/role/DisclosureGeographicInformation Geographic information Notes 21 false false R22.htm 20202 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.bicycletherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of significant accounting policies (Policies) Policies 22 false false R23.htm 30403 - Disclosure - Property and equipment, net (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables Property and equipment, net (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosurePropertyAndEquipmentNet 23 false false R24.htm 30503 - Disclosure - Accrued expenses and other current liabilities (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued expenses and other current liabilities (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 24 false false R25.htm 30603 - Disclosure - Long-term debt (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureLongTermDebtTables Long-term debt (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureLongTermDebt 25 false false R26.htm 30803 - Disclosure - Share-based compensation (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationTables Share-based compensation (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensation 26 false false R27.htm 30903 - Disclosure - Significant agreements (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsTables Significant agreements (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreements 27 false false R28.htm 31103 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables 28 false false R29.htm 31203 - Disclosure - Net loss per share (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureNetLossPerShareTables Net loss per share (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureNetLossPerShare 29 false false R30.htm 31403 - Disclosure - Geographic information (Tables) Sheet http://www.bicycletherapeutics.com/role/DisclosureGeographicInformationTables Geographic information (Tables) Tables http://www.bicycletherapeutics.com/role/DisclosureGeographicInformation 30 false false R31.htm 40101 - Disclosure - Nature of the business and basis of presentation - Liquidity (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationLiquidityDetails Nature of the business and basis of presentation - Liquidity (Details) Details http://www.bicycletherapeutics.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation 31 false false R32.htm 40201 - Disclosure - Summary of significant accounting policies (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of significant accounting policies (Details) Details http://www.bicycletherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 32 false false R33.htm 40301 - Disclosure - Fair value of financial assets and liabilities - Financial assets and liabilities measured at fair value (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureFairValueOfFinancialAssetsAndLiabilitiesFinancialAssetsAndLiabilitiesMeasuredAtFairValueDetails Fair value of financial assets and liabilities - Financial assets and liabilities measured at fair value (Details) Details 33 false false R34.htm 40401 - Disclosure - Property and equipment, net (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosurePropertyAndEquipmentNetDetails Property and equipment, net (Details) Details http://www.bicycletherapeutics.com/role/DisclosurePropertyAndEquipmentNetTables 34 false false R35.htm 40501 - Disclosure - Accrued expenses and other current liabilities (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued expenses and other current liabilities (Details) Details http://www.bicycletherapeutics.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 35 false false R36.htm 40601 - Disclosure - Long-term debt (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureLongTermDebtDetails Long-term debt (Details) Details http://www.bicycletherapeutics.com/role/DisclosureLongTermDebtTables 36 false false R37.htm 40602 - Disclosure - Long-term debt - Debt (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureLongTermDebtDebtDetails Long-term debt - Debt (Details) Details 37 false false R38.htm 40603 - Disclosure - Long-term debt - Future Principal Payments (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureLongTermDebtFuturePrincipalPaymentsDetails Long-term debt - Future Principal Payments (Details) Details 38 false false R39.htm 40701 - Disclosure - Ordinary shares (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureOrdinarySharesDetails Ordinary shares (Details) Details http://www.bicycletherapeutics.com/role/DisclosureOrdinaryShares 39 false false R40.htm 40801 - Disclosure - Share-based compensation (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationDetails Share-based compensation (Details) Details http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationTables 40 false false R41.htm 40802 - Disclosure - Share-based compensation - Share based compensation expense (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationShareBasedCompensationExpenseDetails Share-based compensation - Share based compensation expense (Details) Details 41 false false R42.htm 40803 - Disclosure - Share-based compensation - Share Options (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationShareOptionsDetails Share-based compensation - Share Options (Details) Details 42 false false R43.htm 40804 - Disclosure - Share-based compensation - Assumptions used in the Black Scholes option pricing model to determine the fair value of share options (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfShareOptionsDetails Share-based compensation - Assumptions used in the Black Scholes option pricing model to determine the fair value of share options (Details) Details 43 false false R44.htm 40805 - Disclosure - Share-based compensation - Restricted Share Units (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureShareBasedCompensationRestrictedShareUnitsDetails Share-based compensation - Restricted Share Units (Details) Details 44 false false R45.htm 40901 - Disclosure - Significant agreements - Collaboration revenues (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsCollaborationRevenuesDetails Significant agreements - Collaboration revenues (Details) Details 45 false false R46.htm 40902 - Disclosure - Significant agreements - Ionis Evaluation and Option Agreement (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsIonisEvaluationAndOptionAgreementDetails Significant agreements - Ionis Evaluation and Option Agreement (Details) Details 46 false false R47.htm 40903 - Disclosure - Significant agreements - Ionis Collaboration Agreement (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsIonisCollaborationAgreementDetails Significant agreements - Ionis Collaboration Agreement (Details) Details 47 false false R48.htm 40904 - Disclosure - Significant agreements - Ionis Share Purchase Agreement (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsIonisSharePurchaseAgreementDetails Significant agreements - Ionis Share Purchase Agreement (Details) Details 48 false false R49.htm 40905 - Disclosure - Significant agreements - Ionis (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsIonisDetails Significant agreements - Ionis (Details) Details 49 false false R50.htm 40906 - Disclosure - Significant agreements - Genentech Collaboration Agreement (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsGenentechCollaborationAgreementDetails Significant agreements - Genentech Collaboration Agreement (Details) Details 50 false false R51.htm 40907 - Disclosure - Significant agreements - AstraZeneca Collaboration Agreement (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsAstrazenecaCollaborationAgreementDetails Significant agreements - AstraZeneca Collaboration Agreement (Details) Details 51 false false R52.htm 40908 - Disclosure - Significant agreements - Summary of Contract Assets and Liabilities (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsSummaryOfContractAssetsAndLiabilitiesDetails Significant agreements - Summary of Contract Assets and Liabilities (Details) Details 52 false false R53.htm 40909 - Disclosure - Significant agreements - Deferred revenue (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsDeferredRevenueDetails Significant agreements - Deferred revenue (Details) Details 53 false false R54.htm 40910 - Disclosure - Significant agreements - Revenue recognition due to changes in contract assets and liabilities (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsRevenueRecognitionDueToChangesInContractAssetsAndLiabilitiesDetails Significant agreements - Revenue recognition due to changes in contract assets and liabilities (Details) Details 54 false false R55.htm 40911 - Disclosure - Significant agreements - Cancer Research UK (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureSignificantAgreementsCancerResearchUkDetails Significant agreements - Cancer Research UK (Details) Details 55 false false R56.htm 41001 - Disclosure - Income taxes (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureIncomeTaxesDetails Income taxes (Details) Details http://www.bicycletherapeutics.com/role/DisclosureIncomeTaxes 56 false false R57.htm 41101 - Disclosure - Commitments and Contingencies - Leases, Office and laboratory space Cambridge (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeasesOfficeAndLaboratorySpaceCambridgeDetails Commitments and Contingencies - Leases, Office and laboratory space Cambridge (Details) Details 57 false false R58.htm 41102 - Disclosure - Commitments and Contingencies - Components of lease expense (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingenciesComponentsOfLeaseExpenseDetails Commitments and Contingencies - Components of lease expense (Details) Details 58 false false R59.htm 41103 - Disclosure - Commitments and Contingencies - Leases, Maturities of operating leases (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingenciesLeasesMaturitiesOfOperatingLeasesDetails Commitments and Contingencies - Leases, Maturities of operating leases (Details) Details 59 false false R60.htm 41104 - Disclosure - Commitments and Contingencies - Founder Royalty arrangements (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureCommitmentsAndContingenciesFounderRoyaltyArrangementsDetails Commitments and Contingencies - Founder Royalty arrangements (Details) Details 60 false false R61.htm 41201 - Disclosure - Net loss per share - Basic and diluted net loss per share (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureNetLossPerShareBasicAndDilutedNetLossPerShareDetails Net loss per share - Basic and diluted net loss per share (Details) Details 61 false false R62.htm 41202 - Disclosure - Net loss per share - Securities excluded from the diluted per share calculation (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureNetLossPerShareSecuritiesExcludedFromDilutedPerShareCalculationDetails Net loss per share - Securities excluded from the diluted per share calculation (Details) Details 62 false false R63.htm 41301 - Disclosure - Related party transactions (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureRelatedPartyTransactionsDetails Related party transactions (Details) Details http://www.bicycletherapeutics.com/role/DisclosureRelatedPartyTransactions 63 false false R64.htm 41401 - Disclosure - Geographic information (Details) Sheet http://www.bicycletherapeutics.com/role/DisclosureGeographicInformationDetails Geographic information (Details) Details http://www.bicycletherapeutics.com/role/DisclosureGeographicInformationTables 64 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 26 fact(s) appearing in ix:hidden were eligible for transformation: bcyc:PeriodOverWhichPerformanceObligationsWillBePerformed, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1, us-gaap:FinancialLiabilitiesFairValueDisclosure, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - bcyc-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 3 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies, us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList - bcyc-20220930x10q.htm 9 bcyc-20220930x10q.htm bcyc-20220930.xsd bcyc-20220930_cal.xml bcyc-20220930_def.xml bcyc-20220930_lab.xml bcyc-20220930_pre.xml bcyc-20220930xex10d1.htm bcyc-20220930xex31d1.htm bcyc-20220930xex31d2.htm bcyc-20220930xex32d1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true